Literature DB >> 20205063

[Drug treatment of CRPS].

S Rüegg1.   

Abstract

The main symptoms of excruciating pain, trophic and inflammatory changes, as well as functional impairment of limbs are the hallmark of the complex regional pain syndrome (CRPS). While functional impairments have to be treated by physical and occupational therapy, the former three symptoms are amendable to drug treatment: antidepressants, antiepileptic drugs and opioids are the most important drug classes for alleviating neuropathic pain whereas acute nociceptive pain may be positively influenced by non-steroidal anti-inflammatory drugs and steroids. In addition, calcitonin and the biphosphonates inhibit osteoclasts and therefore loss of bone mass and may thus also reduce pain. The use of sympatholytic agents beyond locoregional anesthesia techniques (which are covered elsewhere in this issue) is not unequivocal. In general, the evidence level for treatment strategies specifically for the complex regional pain syndrome is very poor; most recommendations and algorithms rely on results derived from studies testing drugs against other conditions where chronic (neuropathic) pain is prevalent, like diabetic polyneuropathy or postherpetic neuralgia, or medications are used on the basis of pathomechanistic considerations. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205063     DOI: 10.1055/s-0030-1247501

Source DB:  PubMed          Journal:  Handchir Mikrochir Plast Chir        ISSN: 0722-1819            Impact factor:   1.018


  2 in total

Review 1.  [Leg pain].

Authors:  J Machetanz; L Unger; C Stelzner; U Wollina; S Schellong
Journal:  Internist (Berl)       Date:  2013-11       Impact factor: 0.743

2.  [First degree open, proximal and distal fractures of the lower arm with scapholunate ligament rupture. Case report of severe extremity trauma].

Authors:  U Schmiddem; A Jenzer
Journal:  Unfallchirurg       Date:  2013-12       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.